Kexing Biopharm Co Ltd

SSE:688136

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kexing Biopharm Co Ltd's stock price target?

Not Available

Kexing Biopharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Kexing Biopharm Co Ltd's Revenue forecast?

Projected CAGR

19%

For the last 6 years the compound annual growth rate for Kexing Biopharm Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 19%.

What is Kexing Biopharm Co Ltd's Operating Income forecast?

Projected CAGR

41%

For the last 6 years the compound annual growth rate for Kexing Biopharm Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 41%.

What is Kexing Biopharm Co Ltd's Net Income forecast?

Projected CAGR

108%

For the last 6 years the compound annual growth rate for Kexing Biopharm Co Ltd's net income is -17%. The projected CAGR for the next 3 years is 108%.